Malva sylvestris (Malvaceae) Common Mallow, Khubbaazi, Panirak

Das K
3 hours ago
16 min read

Malva sylvestris, commonly known as common mallow, is a revered medicinal plant with a documented history of human use dating back to 3000 BCE. It is valued in traditional medicine systems across Europe, Asia, and Africa for its potent anti-inflammatory, demulcent, and wound healing properties. The plant is most notably recognized as a soothing remedy for gastrointestinal disorders, respiratory complaints, and skin conditions. Cutting-edge modern research from 2024 to 2026 has revolutionized understanding of this plant, revealing novel mechanisms such as cross-kingdom regulation of human gene expression by plant microRNAs, potent anticancer activity against colon cancer cells, and remarkable wound healing efficacy through advanced nanofiber technology.

---

1. Taxonomic Insights

Species: Malva sylvestris L.

Family: Malvaceae

Taxonomic Note: The species was first described by Carl Linnaeus in 1753. The genus name Malva is derived from the Greek word malache meaning soft or soothing, referring to the emollient properties of the plant. The specific epithet sylvestris means growing in woods or forests, indicating its natural habitat preference.

The Malvaceae family, commonly known as the mallow family, is characterized by mucilaginous properties, stellate trichomes, and showy flowers with numerous stamens fused into a tube. This family is medicinally significant for its demulcent, emollient, and anti-inflammatory properties. The leaves of M. sylvestris exhibit distinct morpho-anatomical characters including non-glandular and glandular trichomes, stellar trichomes, and characteristic stomata on the leaf surfaces.

Related Herbs from the Same Family:

· Althaea officinalis (Marshmallow): A closely related species with similar demulcent and expectorant properties, used for respiratory and gastrointestinal irritation.

· Malva neglecta (Dwarf Mallow): A related species with comparable medicinal uses, often used interchangeably with M. sylvestris in traditional medicine.

· Malva parviflora (Little Mallow): Another medicinal Malva species with antioxidant and anti-inflammatory properties.

· Alcea rosea (Hollyhock): A related ornamental and medicinal plant used for its emollient and anti-inflammatory properties.

---

2. Common Names

---

3. Medicinal Uses

Primary Actions: Demulcent, Emollient, Anti-inflammatory, Antioxidant, Antitussive, Antidiarrheal, Wound healing.

Secondary Actions: Anticancer, Antidiabetic, Antimicrobial, Anticoagulant, Anthelmintic, Hepatoprotective, Anti-ulcer, Skin whitening, Anti-aging.

Medicinal Parts:

The leaves, flowers, roots, and aerial parts are used medicinally, with the leaves and flowers being the most extensively studied.

· Leaves: The primary part used for respiratory conditions, gastrointestinal disorders, and topical applications. Rich in mucilage, flavonoids, and phenolic compounds. Documented to have potent anti-inflammatory, antioxidant, anti-complementary, anticancer, and skin tissue integrity activity.

· Flowers: Used for similar indications and have shown significant antineoplastic potential against colon cancer cells. Contain anthocyanins, flavonoids, and specific microRNAs with cross-kingdom regulatory activity.

· Aerial Parts: The entire above-ground plant is used in traditional medicine for anti-inflammatory effects, particularly against gingivitis, abscesses, and tooth pain.

· Roots: Used for their demulcent properties in traditional preparations.

· Fruits: Exhibit intermediate antioxidant potential with TAA assay of 12.04 mg AAE/g DM and FRAP of 42.26%.

---

4. Phytochemicals Specific to the Plant and Their Action

The phytochemical analysis of M. sylvestris has revealed that the leaves and flowers contain a diverse array of bioactive compounds including flavonoids, mucilages, terpenoids, phenol derivatives, coumarins, sterols, tannins, saponins, and alkaloids.

· Flavonoids (Quercetin, Kaempferol, Epicatechin, Genistein, Myricetin, Malvidin-3-glucoside, Petunidin-3-glucoside): These are major bioactive compounds. They provide Antioxidant, Anti-inflammatory, Anticancer, Skin whitening, and Anti-aging properties. Genistein, an isoflavone, has been identified in flower extracts. Anthocyanins like malvidin-3-glucoside and petunidin-3-glucoside are responsible for the flower color and contribute to antioxidant activity.

· Phenolic Compounds (3-Hydroxytyrosol, Vanillic acid, Chlorogenic acid, Caffeic acid, Gallic acid): These contribute significantly to Antioxidant, Anti-inflammatory, and Cytoprotective effects. 3-Hydroxytyrosol is a potent antioxidant compound also found in olive oil.

· Mucilage (Polysaccharides): A complex mixture of polysaccharides responsible for the Demulcent, Emollient, and Gastroprotective properties. Forms a soothing protective layer over irritated mucous membranes.

· Coumarins (Coumarin derivatives): Exhibit Anticancer, Anti-inflammatory, and Antioxidant activities. One coumarin derivative has shown ROS inhibition effects.

· Malvone A: A naphthoquinone compound responsible for Antibacterial action.

· Phytosterols (β-sitosterol, Stigmasterol): Provide Anti-inflammatory and Cholesterol-lowering effects.

· MicroRNAs (miR160b-5p, miR396c-3p, miR159c-3p, miR6300, miR3954b-5p, miR395c-3p, miR166g-3p, miR164d-5p): Recent research has identified 8 microRNAs typifying the flower tissue. These short non-coding RNAs are stable, resistant to extracellular environments, and capable of cross-kingdom regulation of human gene expression.

· Tannins: Provide Astringent, Antimicrobial, and Wound healing properties.

· Essential Oil Constituents: Various volatile compounds contributing to antimicrobial and anti-inflammatory effects.

· Minerals and Elements: The plant contains essential as well as non-essential elements and minerals, contributing to its nutritional value.

· Fatty Acids: Fatty acid composition has been studied as a chemotaxonomic marker within the Malvaceae family.

---

5. Traditional and Ethnobotanical Uses Covering the Medicinal Uses

History of Use: The consumption of M. sylvestris has been reported to have originated in 3000 BCE. In the region of Syria, archaeological studies have shown the existence of M. sylvestris seeds in dental calculus of human fossils, indicating that the consumption of this species is long-standing due both to it being an edible plant and to its possible medicinal properties.

Kasa (Cough) & Shwasa (Respiratory Disorders)

Formulation: Leaf infusion or decoction.

Preparation & Use: The leaves are used as an antitussive and expectorant for cough, bronchitis, and respiratory irritation. The mucilaginous decoction soothes inflamed respiratory passages. The leaves and flowers are known worldwide due to their anti-inflammatory properties.

Reasoning: The high mucilage content forms a protective film over irritated respiratory mucosa, reducing cough reflex and inflammation. The anti-inflammatory flavonoids address underlying tissue inflammation.

Atisara (Diarrhea) & Grahani (Malabsorption)

Formulation: Leaf decoction; whole plant preparations.

Preparation & Use: The plant is used to treat diarrhea, dysentery, and gastrointestinal disorders. As a medicinal food, it has been consumed as a mild laxative, a liver cleansing tonic, and against heartburn.

Reasoning: The astringent tannins reduce intestinal fluid loss. The mucilage protects inflamed intestinal mucosa. The anti-inflammatory compounds reduce gut inflammation.

Twak Rogas (Skin Disorders) & Vrana (Wounds)

Formulation: Leaf poultice; flower extract; nanofiber dressings (modern application).

Preparation & Use: The leaves and flowers have ample potential for use in the treatment of insect bites, burns, furuncles, and ulcerous wounds. The leaves are used against abscesses, tooth pain, and gingivitis. In modern applications, M. sylvestris extract incorporated into PVA/alginate nanofibrous mats has demonstrated a wound closure rate of 93-94% within 21 days of treatment in rats.

Reasoning: The anti-inflammatory, emollient, and antimicrobial properties promote wound healing. The wound healing activity has been extensively validated. The plant's extract promotes cellular proliferation and angiogenesis.

Shotha (Inflammation) & Sandhivata (Arthritis)

Formulation: Ethanolic leaf extract; leaf poultice.

Preparation & Use: The leaves are used for their anti-inflammatory effects against various inflammatory conditions. In vitro anti-arthritic activity has been scientifically validated.

Reasoning: A 2025 study demonstrated that the ethanolic fraction of M. sylvestris at 500 µg/ml concentration displayed 90% inhibition of egg albumin denaturation with an IC50 value of 59.33±10.26 µg/ml, compared to Diclofenac which had an IC50 value of 47.78±16.20 µg/ml. This validates the traditional use for arthritic conditions.

Parinama Shoola (Gastric Ulcer)

Formulation: Aqueous leaf extract.

Preparation & Use: The aqueous extract has been used traditionally for gastric ulcers.

Reasoning: The anti-ulcerogenic effect has been scientifically proven, with the aqueous extract demonstrating greater effectiveness than cimetidine, a potent medicine used to treat gastric ulcers.

Raktapitta (Bleeding Disorders) & Anticoagulant

Formulation: Various extracts.

Preparation & Use: Traditional applications include use for bleeding disorders.

Reasoning: In vitro studies have confirmed anticoagulant activity. At 25 µg/ml concentration, the ethanolic extract showed 47±0.17% anticoagulant activity compared to 31±0.52% for Albendazole.

Krimiroga (Helminthiasis)

Formulation: Ethanolic, hexane, or chloroform extracts.

Preparation & Use: The plant has traditional anthelmintic applications.

Reasoning: In vitro studies demonstrate significant anthelmintic activity. The ethanolic extract showed 31±0.16% activity at 50 µg/ml concentration against standard parasites.

Madhumeha (Diabetes Mellitus)

Formulation: Leaf extracts.

Preparation & Use: Traditional applications include use for diabetes.

Reasoning: In vitro antidiabetic activity has been confirmed. At 250 µg/ml concentration, the ethanolic extract showed 58±0.02% alpha-amylase inhibition, supporting its traditional use for glycemic management.

Netra Roga (Eye Disorders) & Dry Eye Disease

Formulation: Eye-drop formulations containing Malva extract with hyaluronic acid.

Preparation & Use: In traditional medicine, the plant has been used for eye disorders. Modern research has developed standardized eye-drop formulations.

Reasoning: A 2026 study showed that Malva extract exhibits potent oxygen radical scavenging activity in both cell-free and cell-based assays. The combination of Malva tincture with hyaluronic acid in eye-drop formulations reduces surface tension from 68.17 mN/m to 59.80 mN/m, bringing it closer to that of tear fluid, offering a promising therapeutic approach for managing dry eye disease.

Arbuda (Cancer) & Antineoplastic Potential

Formulation: Flower extract (MFE).

Preparation & Use: The leaves, in particular, have been reported to have anticancer activity.

Reasoning: A 2026 study revealed that M. sylvestris flower extract (MFE) reduced colon cancer cell growth without causing significant cytotoxicity or apoptosis. MFE was able to reduce cell motility and invasiveness in HCT-116 and Caco-2 cell lines. The extract induced senescence in P53-null Caco-2 cells via ROS, β-galactosidase, and P21WAF1/Cip1, and a premise of differentiation in P53-wild-type HCT-116 cells via P27Kip1 through the CDK2/c-MYC/AKT axis. The plant miRNA miR160b-5p was found to target human CDK2 transcript, suggesting its central role in mediating cross-kingdom effects.

---

6. Healing Recipes, Decoctions, and Preparations

Demulcent Leaf Decoction (Respiratory and Digestive Soother)

Purpose: To soothe irritated respiratory and gastrointestinal mucous membranes.

Preparation & Use:

1. Take 2 tablespoons (approximately 10-15 grams) of fresh or dried Malva sylvestris leaves.

2. Simmer gently in 500 ml of water for 10-15 minutes (prolonged boiling may degrade mucilage).

3. Strain and drink warm, 100-150 ml up to three times daily. Honey may be added for cough.

Anti-inflammatory Leaf Poultice (Topical)

Purpose: For skin inflammations, boils, insect bites, and minor wounds.

Preparation & Use:

1. Take a handful of fresh Malva sylvestris leaves.

2. Crush or blend into a soft, mucilaginous paste.

3. Apply directly to the affected area, cover with a clean cloth, and leave for 30-60 minutes.

4. Rinse with warm water. Use twice daily as needed.

Antidiarrheal Leaf Infusion

Purpose: For mild diarrhea and gastrointestinal upset.

Preparation & Use:

1. Steep 1-2 teaspoons of dried leaves in 250 ml of hot water for 10-15 minutes.

2. Strain and drink up to two cups daily. Discontinue if symptoms persist.

Antioxidant Flower Tea

Purpose: General wellness and antioxidant support.

Preparation & Use:

1. Steep 1-2 teaspoons of dried Malva sylvestris flowers in 250 ml of hot water for 10 minutes.

2. Strain and drink once or twice daily. The flowers contain anthocyanins and other beneficial polyphenols.

Medicinal Food Preparations

Preparation & Use: As a medicinal food, Malva has been consumed as a mild laxative, a liver cleansing tonic, and against heartburn. It can be prepared as a soup but is most commonly prepared in salads. The young leaves can be added to salads or cooked as a pot herb similar to spinach.

---

7. In-Depth Phytochemical Profile and Clinical Significance of Malva sylvestris (Common Mallow)

Introduction

Malva sylvestris, the common mallow, represents a remarkable convergence of ancient ethnobotanical wisdom and cutting-edge molecular science. With a documented history of human use spanning over 5,000 years, this humble plant has been a staple of traditional medicine across three continents. Its therapeutic identity has long been associated with the soothing, demulcent properties of its mucilage. However, the years 2024 to 2026 have witnessed a revolutionary transformation in the scientific understanding of M. sylvestris. The discovery that this plant contains microRNAs capable of cross-kingdom regulation of human gene expression has opened entirely new paradigms in pharmacognosy. Concurrent breakthroughs have elucidated its potent antineoplastic activity against colon cancer, its remarkable wound healing efficacy validated through advanced nanofiber technology, and its multi-target pharmacological mechanisms validated through rigorous in vitro studies. M. sylvestris stands at the forefront of a new era in medicinal plant research, where traditional demulcents are being reimagined as sources of gene-regulatory molecules and anticancer agents.

1. MicroRNAs: The Revolutionary Cross-Kingdom Regulatory Mechanism (2023-2026 Breakthrough)

Key Compounds: 33 microRNAs identified in total, including 10 typical for leaves and 2 for flowers. The flower-specific miRNome includes 8 miRNAs: miR160b-5p, miR396c-3p, miR159c-3p, miR6300, miR3954b-5p, miR395c-3p, miR166g-3p, and miR164d-5p.

Quantitative Profile: Next Generation Sequencing revealed that 19 out of 33 detected miRNAs were putatively able to modulate, in plant cells, the expression of various chromosome scaffold proteins. In the human transcriptome, a total of 383 mRNAs involved in 5 fundamental mammalian cellular processes (apoptosis, senescence, cell-cycle, oxidative stress, and invasiveness) theoretically could be bound and regulated by M. sylvestris miRNAs.

Actions and Clinical Relevance:

· Cross-Kingdom Gene Regulation (Revolutionary Discovery): Plant miRNAs have been documented to be very stable, resistant to extracellular environments, absorbable in mammalian cells via exosomes or by RNA transporter membrane proteins, and able to carry out cross-kingdom regulation of mammalian gene expression. This represents a paradigm shift from the traditional view that plant benefits derive solely from phytochemicals.

· Antineoplastic Mechanism via miR160b-5p (2026 Breakthrough): The transfection of tumour cells with pure synthetic miR160b-5p resulted in gene silencing of the human CDK2 transcript. CDK2 (cyclin-dependent kinase 2) is a key regulator of the cell cycle and a validated anticancer target. This finding suggests a central role for this plant miRNA in mediating the cross-kingdom effects of MFE on cancer models, opening new perspectives on the use of plant microRNAs in gene therapy development.

· Physiological Relevance: The evidence collected suggests that the beneficial properties of the use of M. sylvestris, documented by folk medicine, are probably linked to their content of miRNAs and not only to the action of phytochemicals (e.g., anthocyanins). This opens new perspectives about the possibility to develop gene therapies based on miRNAs isolated from medicinal plants.

2. Antineoplastic Activity Against Colon Cancer (2026 Breakthrough)

Key Study: A 2026 study published in Nutrients investigated the antineoplastic potential of M. sylvestris flower extract (MFE) against two human colon cancer cell lines: HCT-116 (P53-wild-type) and Caco-2 (P53-null).

Quantitative Efficacy - Cell Growth Reduction: MTT and Trypan blue assays demonstrated that MFE reduced tumour cell growth without causing significant cytotoxicity or apoptosis, indicating a cytostatic rather than cytotoxic mechanism.

Quantitative Efficacy - Invasion and Motility: Wound assay and transwell tests documented that MFE was able to reduce cell motility and invasiveness in both cell lines. qPCR experiments demonstrated that MFE caused the over-expression of factors like VIMENTIN and E-CADHERIN, which negatively influence epithelial-mesenchymal transition (EMT) in colon cancers. EMT is a key process by which cancer cells gain metastatic potential.

Differential Mechanisms Based on P53 Status:

· In P53-null Caco-2 cells: MFE treatment induced senescence, evidenced by increased ROS production, β-galactosidase activity, and P21WAF1/Cip1 expression. Senescence is a form of permanent growth arrest that prevents cancer cell proliferation.

· In P53-wild-type HCT-116 cells: MFE treatment induced a premise of differentiation via P27Kip1 through the CDK2/c-MYC/AKT axis, explaining its antiproliferative property.

Cellular Uptake: Following fluorescence staining, microscopy analysis proved that MFE components crossed the cell membranes, accumulating into nuclei, demonstrating bioavailability at the subcellular level.

Significance: This study demonstrated for the first time that M. sylvestris flower extract exerts antineoplastic effects through distinct mechanisms dependent on P53 status, and that plant miRNAs play a central role in these effects.

3. Wound Healing and Burn Treatment (2024 Breakthrough)

Key Study (2024): A study published in the International Journal of Pharmaceutics developed polyvinyl alcohol/alginate nanofibrous mats containing M. sylvestris extract (MS) for burn wound applications.

Quantitative Efficacy - Wound Closure: The PVA/ALG/MS1 (M2) dressing demonstrated a wound closure rate of 93-94% within 21 days of treatment in rats, indicating its significant potential for use as a wound dressing agent in the treatment of burn injuries.

Antibacterial Activity: The nanofibrous mats containing MS extracts showed significantly increased antibacterial efficacy against Gram-positive and Gram-negative bacteria. This is attributed to Malvone A and other antimicrobial compounds.

Mechanical and Biological Properties: The combination of PVA, ALG, and MS1 exhibited beneficial properties including biocompatibility, suitable mechanical strength, and the ability to promote cellular proliferation and angiogenesis, further validating its effectiveness as a wound healing dressing.

Fiber Characteristics: Field Emission Scanning Electron Microscopy (FESEM) demonstrated that the fiber diameter ranged from approximately 100-200 nm in nanofibrous mats, with a uniform appearance without beads.

4. Anti-inflammatory and Anti-arthritic Activity (2025 Validation)

Key Study (2025): A study on molecular docking and in vitro studies of M. sylvestris evaluated anti-arthritic, antidiabetic, anticoagulant, anthelmintic, and antioxidant activities.

Quantitative Efficacy - Anti-arthritic: The ethanolic fraction at 500 µg/ml concentration displayed 90% inhibition of protein denaturation with an IC50 value of 59.33±10.26 µg/ml, compared to Diclofenac at 47.78±16.20 µg/ml. The hexane extract showed 88% inhibition (IC50 71.42±11.20 µg/ml), and the chloroform extract showed 73% inhibition (IC50 176.18±9.20 µg/ml).

Quantitative Efficacy - Antidiabetic: At 250 µg/ml concentration, the ethanolic extract showed 58±0.02% alpha-amylase inhibition. At 100 µg/ml, it showed 27±0.21% inhibition, indicating dose-dependent activity.

Quantitative Efficacy - Anticoagulant: At 25 µg/ml concentration, the ethanolic extract showed 47±0.17% anticoagulant activity, while the hexane extract showed 36±0.27% and chloroform extract showed 25±0.29% at the same concentration.

Quantitative Efficacy - Anthelmintic: The ethanolic extract showed 31±0.16% anthelmintic activity at 50 µg/ml concentration against standard parasites, comparable to Albendazole (26±0.52% at 50 µg/ml).

Conclusion: The plant's ethanolic extract was discovered to have the strongest effect on all of the in vitro activities.

5. Ocular Applications and Dry Eye Disease (2026 Breakthrough)

Key Study (2026): A study published in the Journal of Clinical Medicine evaluated the antioxidant activity of M. sylvestris tincture (MalvaT) and its physicochemical properties in experimental eye-drop formulations containing hyaluronic acid (HA) for dry eye disease (DED).

Antioxidant Activity: Malva showed potent oxygen radical scavenging activity in both cell-free and cell-based assays, indicating its antioxidant capacity and the efficient cellular uptake of antioxidant components. This is significant because HA alone cannot correct oxidative stress, a key driver of cellular damage and inflammation in DED.

Physicochemical Properties - Refractive Index: The refractive indices of experimental eye-drop solutions containing HA and MalvaT were close to that of tear fluid (1.334), ensuring optical clarity and compatibility with vision.

Physicochemical Properties - Surface Tension: The surface tension was significantly reduced by increasing concentrations of MalvaT (p < 0.0001). At 0.5% MalvaT, the mean surface tension was reduced from 68.17 mN/m (HA control) to 59.80 mN/m (HA + MalvaT), thereby bringing it closer to that of tear fluid (approximately 43-46 mN/m). Lower surface tension improves spreading on the ocular surface and tear film stability.

Conclusion: This pre-clinical study suggests that combining the antioxidant properties of Malva tincture with the lubricating and hydrating effects of HA in eye-drop formulations may offer a promising therapeutic approach for managing DED.

6. Antioxidant and Phytochemical Profile (2023-2025 Studies)

Quantitative Phytochemical Profile (2025 Study on Fruits): M. sylvestris fruits exhibited intermediate antioxidant potential compared to other Malva species. Total Antioxidant Activity (TAA) was 12.04 mg AAE/g DM, and FRAP (ferric reducing antioxidant power) was 42.26%. The fruit extracts from the three studied Malva species exhibited antioxidant activity, supporting the use of Malva fruits in traditional food and medicine.

Quantitative Phytochemical Profile (Leaves): Leaf extracts of M. sylvestris have shown total phenolics of 2.34 mg GAE/g DM and total flavonoids of 0.694 ± 0.017 mg RE/100 g. Methanolic extracts of leaves and flowers showed strong antibacterial activity against common plant pathogen bacteria.

Extraction Optimization (2023 Study): 95% ethanol extracts showed the worst capacity in isolating total phenols and flavonoids, while all hydroalcoholic samples revealed a specific ability in purifying anthocyanins. HPLC-DAD system detected and quantified 20 phenolic secondary metabolites, whose concentration in various extracts depended on their chemical nature and the percentage of ethanol used in preparation.

An Integrated View of Healing in Malva sylvestris

· For Cancer Treatment (Colorectal Cancer): M. sylvestris has been radically reimagined from a simple demulcent to a potential source of anticancer therapy. The 2026 discovery of miR160b-5p targeting human CDK2 transcript represents a paradigm shift in understanding how medicinal plants work. The plant miRNA is stable, absorbable, and capable of gene regulation across kingdoms. The flower extract simultaneously induces senescence in P53-null cancer cells and differentiation in P53-wild-type cells through the CDK2/c-MYC/AKT axis. The antimetastatic effect through reduced cell motility and invasiveness and the modulation of EMT markers (VIMENTIN, E-CADHERIN) further enhance its anticancer profile. The identification of specific plant miRNAs opens possibilities for gene therapy development.

· For Wound Healing and Burn Treatment: The 2024 development of PVA/alginate nanofibrous mats containing MS extract represents a successful translation of traditional knowledge into advanced biomedical technology. The 93-94% wound closure rate within 21 days in rat models demonstrates remarkable efficacy. The broad-spectrum antibacterial activity (both Gram-positive and Gram-negative) prevents wound infection, a major complication in burn care. The promotion of cellular proliferation and angiogenesis ensures proper tissue regeneration. The biocompatibility and suitable mechanical strength of the nanofibrous mats make them clinically viable.

· For Inflammatory and Arthritic Conditions: The 2025 validation of anti-arthritic activity provides robust scientific support for centuries of traditional use. The 90% inhibition of protein denaturation at 500 µg/ml, comparable to Diclofenac, is clinically significant. The multi-extract comparison (ethanolic being most potent, hexane intermediate, chloroform least) provides guidance for extraction standardization. The simultaneous anti-inflammatory, analgesic, and antioxidant activities work synergistically.

· For Ocular Health and Dry Eye Disease: The 2026 development of Malva-containing eye-drop formulations addresses a major global health concern affecting 34-50% of the population. The dual functionality of lubricating (HA) and antioxidant (Malva) components breaks the vicious cycle of DED where oxidative stress drives inflammation and tissue damage. The optimized physicochemical properties (refractive index matching tear fluid, reduced surface tension) ensure patient comfort and compliance.

· For Gastrointestinal and Respiratory Health (Traditional Validated): The traditional applications are now mechanistically understood through multiple pathways. The mucilage provides direct demulcent protection to irritated mucosa. The anti-inflammatory flavonoids reduce underlying tissue inflammation. The antimicrobial compounds address infectious components. The anti-ulcerogenic effect superior to cimetidine positions it as a potential treatment for gastric ulcers. The antidiarrheal activity through multiple mechanisms (astringent, antimicrobial, anti-motility) validates traditional use.

Toxicological Profile and Quality Control

Safety Profile: The literature data indicate that M. sylvestris is safe at low concentrations, although further research is required to evaluate potential negative consequences associated with high dosages and prolonged consumption.

Standardization Parameters: The establishment of HPLC-DAD methods for detecting and quantifying 20 phenolic secondary metabolites provides a foundation for quality control. The identification of extraction parameters (hydroalcoholic better for anthocyanins, 95% ethanol less effective for total phenols) guides preparation standardization. The identification of specific microRNA profiles for leaves (10) and flowers (2) provides novel molecular markers for authentication.

Caution: Like all medicinal plants, professional guidance is recommended for therapeutic use, and pregnant and lactating women should consult healthcare providers before use.

Conclusion: Malva sylvestris has undergone one of the most remarkable transformations in the history of medicinal plant research. From a humble weed known for its soothing mucilage, it has emerged as a plant of revolutionary scientific importance. The discovery of its microRNAs capable of cross-kingdom regulation of human genes, particularly miR160b-5p targeting CDK2, opens entirely new paradigms in pharmacognosy and gene therapy. The validation of its potent antineoplastic activity against colon cancer, its 93-94% wound closure efficacy through advanced nanofiber technology, and its anti-arthritic activity comparable to Diclofenac collectively position M. sylvestris as a plant of extraordinary therapeutic potential. It stands as a bridge between ancient wisdom and future medicine, offering validated applications in oncology, wound care, ophthalmology, and inflammation. The identification of specific bioactive molecules miRNAs, flavonoids, phenolic compounds, and mucilage and their mechanisms of action provides clear pathways for the development of standardized phytomedicines, advanced drug delivery systems, and gene-based therapies.

---

Disclaimer:

Malva sylvestris is generally considered safe based on extensive traditional use and modern literature data indicating safety at low concentrations. However, further research is required to evaluate potential negative consequences associated with high dosages and prolonged consumption. Pregnant and breastfeeding women should consult a healthcare provider before therapeutic use. Individuals with diabetes should use under professional supervision due to potential hypoglycemic effects. Always consult a qualified healthcare professional before using this plant for medicinal purposes. This information is for educational use only and is not a substitute for professional medical advice.

---

8. Reference Books, Books for In-depth Study:

· Medicinal Plants of the World by Ben-Erik van Wyk and Michael Wink

· The Essential Guide to Herbal Safety by Simon Mills and Kerry Bone

· Journal of Pharmacy and Pharmacology (2012 review issue for M. sylvestris)

· Combinatorial Chemistry & High Throughput Screening (2024 issue for M. sylvestris)

· Nutrients journal (2026 issue for MFE and colon cancer)

---

9. Further Study: Plants That Might Interest You Due to Similar Medicinal Properties

1. Althaea officinalis (Marshmallow)

· Species: Althaea officinalis | Family: Malvaceae

· Similarities: The closest relative in terms of medicinal use, sharing the demulcent, emollient, and anti-inflammatory properties of M. sylvestris. Marshmallow is more specifically used for urinary tract irritation and dry cough, while M. sylvestris has broader applications including more potent anticancer and wound healing properties.

2. Plantago major (Broadleaf Plantain)

· Species: Plantago major | Family: Plantaginaceae

· Similarities: Another ubiquitous "weed" with similar demulcent, anti-inflammatory, and wound healing properties. Both are used topically for insect bites, wounds, and skin inflammations, and internally for respiratory and gastrointestinal irritation. Plantain contains aucubin with specific antimicrobial properties.

3. Ulmus rubra (Slippery Elm)

· Species: Ulmus rubra | Family: Ulmaceae

· Similarities: Slippery elm inner bark is a classic demulcent used for similar indications gastrointestinal irritation, sore throat, and cough. Both plants contain abundant mucilage that soothes inflamed mucous membranes. Slippery elm is more specifically used for acid reflux and inflammatory bowel conditions.

4. Calendula officinalis (Pot Marigold)

· Species: Calendula officinalis | Family: Asteraceae

· Similarities: Calendula shares with M. sylvestris potent anti-inflammatory, wound healing, and skin-soothing properties. Both are used topically for burns, wounds, and skin inflammations. Calendula is more specifically used for delayed wound healing and as an antifungal agent, while M. sylvestris offers unique anticancer and microRNA-based mechanisms.

-x-x-x-End-x-x-x-

PREHEALING

Malva sylvestris (Malvaceae) Common Mallow, Khubbaazi, Panirak

Recent Posts

Comments